XETRA - Delayed Quote EUR
AbbVie Inc. (4AB.DE)
158.40
+3.60
+(2.33%)
At close: April 24 at 5:35:41 PM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.8M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| STEWART JEFFREY RYAN Officer | Sale at price 209.49 - 210.54 per share. | Direct | 12,359,504 | Mar 31, 2025 |
| GONZALEZ RICHARD A Director | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 31, 2025 |
| STEWART JEFFREY RYAN Officer | Conversion of Exercise of derivative security at price 79.02 per share. | Direct | 2,030,814 | Mar 31, 2025 |
| REENTS SCOTT T. Chief Financial Officer | Sale at price 212.34 per share. | Direct | 3,746,527 | Mar 14, 2025 |
| RICHMOND TIMOTHY J Officer | Sale at price 209.80 - 211.32 per share. | Direct | 4,472,039 | Mar 3, 2025 |
| SIATIS PERRY C. General Counsel | Sale at price 205.38 - 210.00 per share. | Direct | 5,822,402 | Mar 3, 2025 |
| GONZALEZ RICHARD A Director | Sale at price 205.11 - 210.53 per share. | Direct | 20,263,020 | Mar 3, 2025 |
| SIATIS PERRY C. General Counsel | Conversion of Exercise of derivative security at price 144.54 - 175.28 per share. | Direct | 2,879,040 | Mar 3, 2025 |
| RICHMOND TIMOTHY J Officer | Sale at price 201.97 - 203.64 per share. | Direct | 6,070,036 | Feb 26, 2025 |
| BUCKBEE KEVIN K Officer | Sale at price 203.40 - 203.41 per share. | Direct | 3,853,372 | Feb 26, 2025 |
| RICHMOND TIMOTHY J Officer | Conversion of Exercise of derivative security at price 114.36 per share. | Direct | 2,539,936 | Feb 26, 2025 |
| BUCKBEE KEVIN K Officer | Conversion of Exercise of derivative security at price 93.50 - 105.92 per share. | Direct | 1,601,313 | Feb 26, 2025 |
| SIATIS PERRY C. General Counsel | Sale at price 197.40 - 198.12 per share. | Direct | 1,143,453 | Feb 20, 2025 |
| RICHMOND TIMOTHY J Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2025 |
| SALEKI-GERHARDT AZITA Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2025 |
| MICHAEL ROBERT A. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2025 |
| GONZALEZ RICHARD A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2025 |
| REENTS SCOTT T. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2025 |
| SIATIS PERRY C. General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2025 |
| BUCKBEE KEVIN K Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2025 |
| THAKKAR ROOPAL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2025 |
| STEWART JEFFREY RYAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2025 |
| DONOGHOE NICHOLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2025 |
| BUCKBEE KEVIN K Officer | Sale at price 172.24 per share. | Direct | 310,032 | Dec 16, 2024 |
| BUCKBEE KEVIN K Officer | Conversion of Exercise of derivative security at price 93.50 per share. | Direct | 168,300 | Dec 16, 2024 |
| GONZALEZ RICHARD A Officer and Director | Stock Gift at price 0.00 per share. | Direct | 0 | Sep 30, 2024 |
| SALEKI-GERHARDT AZITA Chief Operating Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Sep 24, 2024 |
| GONZALEZ RICHARD A Officer and Director | Sale at price 186.52 per share. | Direct | 12,403,580 | Aug 5, 2024 |
| GONZALEZ RICHARD A Officer and Director | Sale at price 175.00 per share. | Direct | 49,497,875 | Jul 17, 2024 |
| GONZALEZ RICHARD A Officer and Director | Conversion of Exercise of derivative security at price 61.36 - 93.50 per share. | Direct | 21,919,048 | Jul 17, 2024 |
| GONZALEZ RICHARD A Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Jun 28, 2024 |
| WADDELL FREDERICK H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2024 |
| BURNSIDE WILLIAM H L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2024 |
| HART BRETT J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2024 |
| RAPP EDWARD J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2024 |
| ALPERN ROBERT J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2024 |
| MEYER MELODY B Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2024 |
| ROBERTS REBECCA B. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2024 |
| DAVIS JENNIFER L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2024 |
| QUAGGIN SUSAN E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2024 |
| FREYMAN THOMAS C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2024 |
| AUSTIN ROXANNE SCHUH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2024 |
| TILTON GLENN FLETCHER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2024 |
| DONOGHOE NICHOLAS Officer | Sale at price 176.30 per share. | Direct | 3,716,757 | Mar 20, 2024 |
| STEWART JEFFREY RYAN Officer | Sale at price 178.69 - 179.03 per share. | Direct | 10,539,508 | Mar 18, 2024 |
| STEWART JEFFREY RYAN Officer | Conversion of Exercise of derivative security at price 61.36 per share. | Direct | 1,602,110 | Mar 18, 2024 |
| RICHMOND TIMOTHY J Officer | Sale at price 176.35 - 177.71 per share. | Direct | 13,415,503 | Mar 1, 2024 |
| RICHMOND TIMOTHY J Officer | Conversion of Exercise of derivative security at price 61.36 per share. | Direct | 2,804,152 | Mar 1, 2024 |
| MICHAEL ROBERT A. President | Sale at price 176.44 - 176.46 per share. | Direct | 12,153,957 | Feb 29, 2024 |
| SIATIS PERRY C. General Counsel | Sale at price 177.05 - 178.04 per share. | Direct | 1,754,555 | Feb 29, 2024 |
Related Tickers
C43.DE Cosmo Pharmaceuticals N.V.
50.00
0.00%
GIS.DE Gilead Sciences, Inc.
94.56
+1.74%
IDP.DE Biogen Inc.
105.50
+1.49%
SNW.DE Sanofi
93.33
-0.07%
BRM.DE Bristol-Myers Squibb Company
42.60
+0.73%
GS71.DE GSK plc
16.43
+1.33%
ZEG.DE AstraZeneca PLC
122.30
+1.03%
6MK.DE Merck & Co., Inc.
68.90
-0.58%
AMG.DE Amgen Inc.
246.90
+0.24%
NOTA.F Novartis AG
94.80
-2.87%